Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Significant progress has been made in prospectively designing molecules using the central nervous system multiparameter optimization (CNS MPO) desirability tool, as evidenced by the analysis reported herein of a second wave of drug candidates that originated after the development and implementation of this tool. This simple-to-use design algorithm has expanded design space for CNS candidates and has further demonstrated the advantages of utilizing a flexible, multiparameter approach in drug discovery rather than individual parameters and hard cutoffs of physicochemical properties. The CNS MPO tool has helped to increase the percentage of compounds nominated for clinical development that exhibit alignment of ADME attributes, cross the blood-brain barrier, and reside in lower-risk safety space (low ClogP and high TPSA). The use of this tool has played a role in reducing the number of compounds submitted to exploratory toxicity studies and increasing the survival of our drug candidates through regulatory toxicology into First in Human studies. Overall, the CNS MPO algorithm has helped to improve the prioritization of design ideas and the quality of the compounds nominated for clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, A11 scores 4.8 out of 6 on the central nervous system multiparameter optimization (CNS MPO; Wager et al., 2016) desirability index, indicating favorable structural properties for CNS drug development (Fig. S4 d).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Wager et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, A11 scores 4.8 out of 6 on the central nervous system multiparameter optimization (CNS MPO; Wager et al., 2016) desirability index, indicating favorable structural properties for CNS drug development (Fig. S4 d).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Wager et al., 2016
In the citing paper
“Clearly, molecular weight is a physicochemical parameter fundamental for CNS penetration and for the overall profile of drugs against neurodegenerative diseases.103,104”
From From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology (2021) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100008c · Cited by 1,063
Self-citationPhysiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Self-citationCNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Rankovic, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 548
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Self-citationGhose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200100h · Cited by 447
Feng, B., Mills, J. B., Davidson, R. E., Mireles, R. J., Janiszewski, J. S., Troutman, M. D., & de Morais, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017434 · Cited by 440
Development of a new permeability assay using low‐efflux MDCKII cells
Di, L., Whitney‐Pickett, C., Umland, J. P., Zhang, H., Zhang, X., Gebhard, D. F., Lai, Y., Federico, J. J., Davidson, R. E., Smith, R., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22674 · Cited by 313
Hosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
Ertl, P. (2007) · Methods and principles in medicinal chemistry · doi:10.1002/9783527621286.ch5 · Cited by 75
Research works printed but not linked: 1
- Harrington, E. C., Jr. (1965) The desirability function. Indust. Qual. Control 21, 494-498.
Cited by
Items 501–600 of 746
Alzheimer’s Disease Drug Discovery in Academia: From High-Throughput Screening to In Vivo Testing
Brunden, K. R., Nzou, G., & Ballatore, C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.004 · Cited by 1
da Fonseca, A. M., Cabongo, S. Q., Caluaco, B. J., Colares, R. P., Fernandes, C. F. C., dos Santos, H. S., de Lima‐Neto, P., & Marinho, E. S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2148128 · Cited by 1
“The physicalchemical properties convenient to Lipinski’s rule of five drug-likeness (RO5) filters (Lipinski, 2004), Veber rule (GSK) (Veber et al., 2002) and Pfizer rules (Hughes et al., 2008), such as molecular weight (MW), partition coefficient (logP), topological polar surface area (TPSA) and the number of rotatabl…”
BackgroundInfluentialN -Sulfonylphenoxazines as neuronal calcium ion channel blockers
Schmit, M., Hasan, M. M., Dongol, Y., Cardoso, F. C., Kuiper, M. J., Lewis, R. J., Duggan, P. J., & Tuck, K. L. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00336e · Cited by 1
Rocha, M. B. M., da Silva, L. E., do Amaral, W., Deschamps, C., Rebelo, R. A., Begnini, I. M., Boyen, A. D., Ferreira, M. K. A., Mendes, F. R. D. S., Marinho, E. S., et al. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141927 · Cited by 1
Pereira, W. F., Pessoa, C., da Rocha, M. N., Marinho, E. M., Dias, J. M. L., Almeida-Neto, F. W. Q., Coutinho, H. D. M., de Carvalho, G. G. C., Márcia, M. M., Marinho, E. S., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151612 · Cited by 1
Recent highlights in covalent inhibitor design
Marino, K. A., Nicewonger, R., Zhang, H., & Thorarensen, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00010-8 · Cited by 1
Barbosa, W. A., Silva, J., de Oliveira, V. M., da Rocha, M. N., Almeida-Neto, F. W. Q., Marinho, M. M., & Marinho, E. S. (2025) · Next research. · doi:10.1016/j.nexres.2025.100355 · Cited by 1
Drug discovery technologies–Current and future trends
Noe, M. C., Steppan, C. M., & Weston, A. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00019-4 · Cited by 1
Kaulić, V. R., Piškor, M., Koštrun, S., Milić, A., Stojković, M. R., Francisco, A. F., Taylor, M. C., Kelly, J. M., & Raić‐Malić, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117854 · Cited by 1
Borges, J. A. D. O., Freitas, P. R., Araújo, I. M., de Almeida, R. S., Nascimento, I. J. D. S., de Araújo‐Júnior, J. X., da Silva‐Júnior, E. F., de Aquino, T. M., Mendonça, F. J. B., Marinho, E. S., et al. (2025) · ChemistryOpen · doi:10.1002/open.202500260 · Cited by 1
Evaluation of the Activity of Amino Chalcone Against Staphylococcus Strains Harboring Efflux Pumps
Donato, I. A., Barbosa, C. R. D. S., Bezerra, A. H., Bezerra, S. R., de Almeida, R. S., Oliveira–Tintino, C. D. D. M., Araújo, I. M., Rodrigues, E. Y. D. S., de Oliveira, M. Y. C., Cajazeiras, F. F. M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18111629 · Cited by 1
The Significant Role of Nitrogen Protonation in the Rational Design of Tau-PET Tracers
Liu, T., Li, Y., Ren, C., Song, J., Wu, N., Wang, Y., Huang, Z., Zhang, Q., Qi, Z., Dai, J., et al. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.109367 · Cited by 1
Silva, J. B., da Rocha, M. N., Freire, V. N., Ayala, A. P., Caetano, E. W. S., dos Santos, R. C. R., Silva, B. P. E., Cajazeiras, F. F. M., Dias, J. M. L., Guedes, J. M., et al. (2025) · Chemical Papers · doi:10.1007/s11696-025-04515-5 · Cited by 1
Hedwig, V., Spöring, M., Aspnes, G. E., Gottschling, D., Klein, H., Klugmann, M., Kreuz, S., Ries, B., Schnapp, G., Scharsich, S., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.5c00739 · Cited by 1
Marinho, E. M., Lúcio, F. N. M., da Rocha, M. N., de Oliveira, V. M., de Almeida-Neto, F. W. Q., Marinho, M. M., Marinho, E. S., & de Lima-Neto, P. (2026) · Molecular Diversity · doi:10.1007/s11030-025-11446-6 · Cited by 1
“OH group exhibits additive polarity properties (TPSA OH : 20.23 Å 2 ) in the CCB2 and CCB3 compounds, thereby optimizing the TPSA to a threshold that favors BBB permeability with safety to the CNS, as per the established rule by Pfizer, Inc. (TPSA > 40 Å 2 ) [12, 69 ].”
InfluentialLopes, P. P. J., Ayran, M. A. S., João, P. P., Colares, R. P., Lima, J. R. C., Neto, M. M., da Rocha, M. N., Marinho, E. S., dos Santos, H. S., Ferreira, A. N. S., et al. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100193 · Cited by 1
Rossebø, A. G., Kolberg, H. G., Tønder, A. E., Kjærulff, L., Hansen, P. E., Frydenvang, K., Østergaard, J., & Kristensen, J. L. (2026) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.22.11 · Cited by 1
Henderson, S. H., Ringuette, A. E., Whomble, D. L., Capstick, R. A., Richardson, A. E., Maurer, M. A., Billard, N. B., Lei, X., Wilkinson, J. C., Kethanapalli, S. H., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00896 · Cited by 1
Smith, J. R., Toro, A. R., Sabater, A. A., Kovacic, S., Ban, F., Arévalo, A. P., Crispo, M., Gueron, G., Young, R. N., & Cherkasov, A. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-36842-2 · Cited by 1
“…group disclosure of Nirmatrelvir’s design (then referred to as PF-07321332 14 ), which suggested that this modification could enhance metabolic stability and gut permeability by reducing the number of reactive methines, rotatable bonds, and hydrogen bond donors, compared to VPC285786 31–33 .”
Jangwan, N. S., Jhangiani, P., Jain, S., Haider, S., Kumar, A., Jain, G. K., & Tewari, D. (2026) · ChemistrySelect · doi:10.1002/slct.202507173 · Cited by 1
Wilkinson, C. S., Bruns, N., Pince, C. L., McGinn, M. A., Farokhnia, M., Leggio, L., & Vendruscolo, L. F. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07035-6 · Cited by 1
Bonifacio, D., Furnari, S., & Condorelli, G. A. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107159 · Cited by 1
Fisher, E. L., Schmitt, A. D., Tuttle, J. B., Unwalla, R. J., Lovett, G., Kormos, B. L., Coffman, K. J., Zhou, D., Moran, M., Williams, J., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00081 · Cited by 1
Idrissi, I. G. E., Spinaci, A., Vitone, D., Intranuovo, F., Niso, M., Brunetti, L., Francucci, B., Pazarlar, B. A., Magnusdottir, K. H., Paradies, E., et al. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00820 · Cited by 1
Yoshikawa, H., Yoshida, E., 松本崇宏, Sugita, K., Kamiya, S., Ohgita, T., Kobuchi, S., Shimohama, S., & Takata, K. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118664 · Cited by 1
Jakubiec, M., Zagaja, M. P., Socała, K., Abram, M., Mogilski, S., Latacz, G., Szafarz, M., Szala‐Rycaj, J., Karnafał-Ziembla, J., Kudrycka, M., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02093 · Cited by 1
Millard, M., Dzedulionytė, K., Kilian, J., Mair, V., Hölzer, W., Hacker, M., Langer, T., Ozenil, M., & Pichler, V. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109932 · Cited by 1
Synthesis, antioxidant capacity and aggregation of carotenoid-curcumin conjugates and hybrids
Jijón, S., Czett, D., Böddi, K., Gulyás‐Fekete, G., Nagy, V., Takátsy, A., Balogh, G. T., Deli, J., & Agócs, A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347640 · Cited by 1
“The polar surface area of the new compounds does not significantly exceed the 120 Å 2 value for oral absorption (exception of 9 , 11 and 12 ), while the 90 Å 2 limit related to BBB permeability [31] is met only by compounds 2 , 3 and 5 .”
Czarnota-Łydka, K., Kucwaj‐Brysz, K., Cios, A., Mordyl, B., Głuch‐Lutwin, M., Jastrzębska‐Więsek, M., Partyka, A., Honkisz-Orzechowska, E., Karcz, T. P., Pakulska, J., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118966 · Cited by 1
Arroyo‐Urea, S., Nazarova, A. L., Knieb, A., Abdulsalam, H., Jahan, K., Du, T., Gao, S., Newman, A. H., Katritch, V., García‐Nafría, J., et al. (2026) · JACS Au · doi:10.1021/jacsau.6c00654 · Cited by 1
Jahan, K., Glatfelter, G. C., Sanchez, J., Maitland, A. D., Bonifazi, A., Saab, E., Keegan, B. M., Rais, R., Bi, G., Gomez, J. L., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119079 · Cited by 1
PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives
Degennaro, P., Idrissi, I. G. E., Purgatorio, R., Fanizzi, A., Rullo, M., Pisani, L., Macchia, E., Torsi, L., Stefanachi, A., & Leonetti, F. (2026) · Pharmaceuticals · doi:10.3390/ph19091352 · Cited by 1
“…exposure, optimization leverage is built into every phase of discovery: in silico models (Pfizer’s CNS Multi-Parameter Optimization score, CNS-MPO) [70] drive initial design and in vitro assays (cell-free PAMPA-BBB, traditional 2D cell cultures, 3D organoids, emerging microfluidic organ-on-a-chip…”
Design and Exploration of a Tricyclic Series of CNS-Penetrant CD38 Small Molecule Inhibitors
Hodges, T. R., Jang, Y., Korch, K. M., Osuma, A., Randolph, J. T., Shiroodi, R., Bergstrom, B. D., Brosey, C. A., Jejurkar, P., Sheehan, M. M., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00301 · Cited by 1
Vallaster, B., Forster, L., Bresinsky, M., Wirth, L., Fuller, J. L., Shi, K., Lapcinski, I. P., Liu, P., Mudaliar, D. J., Hubmann, A., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01371 · Cited by 1
Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain
Pissarek, M. (2017) · World Journal of Neuroscience · doi:10.4236/wjns.2017.71010 · Cited by 1
Aguiar, G. R., Lemos, T. L. G., Braz‐Filho, R., da Fonseca, A. M., Marinho, E. S., Ribeiro, P. R. V., Canuto, K. M., & Monte, F. J. Q. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2133010 · Cited by 1
“database (Wager et al., 2016), where the final MPO score of 3.”
BackgroundInfluentialTHE SEROTONIN 5-HT 2A RECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Bolinger, A. A., Anastasio, N. C., Cunningham, K. A., & Zhou, J. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch03 · Cited by 1
Eyal, A. D., & Eyal, S. (2024) · Epilepsia · doi:10.1111/epi.17978 · Cited by 1
“8,9 Such tools build upon selected sets of physicochemical characteristics for predicting the absorption, toxicity, and CNS activity of investigational compounds.”
Брель, А. К., Лисина, С. В., DYACHKOV, S. I., & Budaeva, J. N. (2024) · IZVESTIA VOLGOGRAD STATE TECHNICAL UNIVERSITY · doi:10.35211/1990-5297-2024-5-288-37-45 · Cited by 1
Exploring the therapeutic potential of chalcones for anxiety and epilepsy in adult Zebrafish
Matos, M. G. C., Guedes, J. M., da Rocha, M. N., Marinho, E. S., Marinho, M. M., Ribeiro, W. H. F., Ferreira, M. K. A., Cajazeiras, F. F. M., Dias, J. M. L., Lemos, C. G., et al. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.114154 · Cited by 1
Mendes, J. W. D. S., do Nascimento, J. B., Viturino, J. J. F., Nascimento, L. L. L., Leite, D. O. D., de Carvalho, N. K. G., dos Santos, H. S., Marinho, E. S., Marinho, M. M., de Menezes, J. E. S. A., et al. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100789 · Cited by 1
da Silva, A. J. A., Silveira, Z. D. S., Macêdo, N. S., Barbosa, C. R. D. S., Sousa, Â. E. D. S., da Silva, T. F., de Sousa, J. T., Oliveira–Tintino, C. D. D. M., Tintino, S. R., Marinho, E. S., et al. (2025) · Biologia · doi:10.1007/s11756-025-01978-5 · Cited by 1
“According to Wager et al. (2016), compounds that are less lipophilic (logP ≤ 3) and more polar than compounds active in the central nervous system (TPSA > 20–40 Å 2 ) exhibit greater cellular viability and safety, a profile aligned with compounds showing high apparent cellular permeability (P app,…”
InfluentialBraïki, A. (2018) · theses.fr (ABES) · doi:10.70675/2c4e1c72za4faz40bczb456zd2ea6840983e · Cited by 1
Pons, M. (2019) · theses.fr (ABES) · doi:10.70675/75f4a497zf3cez442dza5a6zf016abc384ad · Cited by 1
Enhancing Reaction-based de novo Design using Machine Learning
Ghiandoni, G. M. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
da Silva, G. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2023.tde-13062023-075448 · Cited by 1
Lima, I. K. C., Lúcio, F. N. M., Gomes, A. O. C. V., Coutinho, H. D. M., Cajazeiras, F. F. M., Rocha, J. E., Guedes, J. M., da Rocha, M. N., Marinho, M. M., Canuto, K. M., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4775685 · Cited by 1
Modulation of the Tumor Microenvironment To Overcome Glioblastoma Treatment Resistance
Ahmed, M. H. (2021) · theses.fr (ABES) · doi:10.70675/25ed4d34z9ef1z4b7bza992z41c9ad48acaf · Cited by 1
Design and Biological Activity of a Novel Brain Penetrant Urea Compound Against GlioblastomaPreprint
He, L., Chen, X., Ding, H., Azizad, D. J., Hoffman, C., Azizi, L., Elezi, G., Zhuang, Z., Cardenas, A. M., Calderon, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.10.648292 · Cited by 1
Clayton, W. B., Putt, K. S., Richardson, T. I., Beck, D. E., Massey, S. M., Utsuki, T., Visvanathan, R., Chu, S., Mason, E. R., & IUSM-Purdue TREAT-AD Center (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8264112 · Cited by 1
In Silico Design of Drug-Like Molecules with Evolutionary Algorithms and Transformers
Cofala, T. (2023) · Carl von Ossiezky University of Oldenburg · Cited by 1
Blood-Brain Barrier Exclusion (BBBX) Score: Designing Drugs Not to Enter the BrainPreprint
Ziadat, S., Noden, M., Liu, Y., Weaver, D. F., & Reed, M. A. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15000184/v1 · Cited by 1
Blood-Brain Barrier Exclusion (BBBX) Score: Designing Drugs Not to Enter the BrainPreprint
Ziadat, S., Noden, M., Yu, L., Weaver, D. F., & Reed, M. A. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15000184/v2 · Cited by 1
Reflections on 2016 and Projecting Forward
Lindsley, C. W. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00146
Tumeurs du système nerveux central et expositions agricoles aux pesticides
Piel, C. (2018) · theses.fr (ABES) · doi:10.70675/339552d4zd75bz4b18z8a57za82257a3838d
West, R. (2019) · Sussex Research Online (University of Sussex)
ACS Chemical Neuroscience: Most Cited Papers from 2016
Lindsley, C. W. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00354
Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors
Kim, M. (2018) · University of Minnesota Digital Conservancy (University of Minnesota)
Design, synthesis, and evaluation of drugs repurposed for infectious disease drug discovery
Spaulding, A. E. (2018) · Digital Repository Service (Northeastern University) · doi:10.17760/d20316334
Hudson, I. L., Leemaqz, S., & Abell, A. D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160233-00251
Svec, R. L. (2020) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Bung, N., Krishnan, S. R., & Roy, A. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-s9l6x
“…properties such as octanol-water partition coefficient (logP), molecular weight (MW), polar surface area (PSA), and hydrogen bonding (Fong et al., 2015, Wager 2010, Wager 2016) are important factors governing the BBB permeability of molecules targeting proteins of the central nervous system.”
BackgroundBung, N., Krishnan, S. R., & Roy, A. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-s9l6x-v2
da Rocha, M. N., Bezerra, L. L., Silva, L. P., Almeida-Neto, F. W. Q., Marinho, M. M., dos Santos, H. S., Neto, P. L., & Marinho, E. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1543551/v1
Lowe, J. A., III (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740105200.793585637
Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic StabilityPreprint
Sorrentino, J. P., & Altman, R. A. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14495748
Central Nervous System Multiparameter Optimization Desirability
Talevi, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_150
New Approaches in the Treatment of Glioblastoma Multiforme
Morgan, L. R., Jursic, B. S., Ware, M. L., & Weiner, R. S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.105886
Andres‐Mach, M., Zagaja, M. P., Szala‐Rycaj, J., Szewczyk, A., Abram, M., Jakubiec, M., Ciepiela, K., Socała, K., Właź, P., Latacz, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098302
“cut-off point for selecting compounds for hit finding in CNS drug discovery programs [15].”
BackgroundPOSITRON EMISSION TOMOGRAPHY NEUROIMAGING IN DRUG DISCOVERY AND DEVELOPMENT
Cole, E. L., & Drake, L. R. (2022) · Medicinal chemistry reviews · doi:10.1021/mc-2022-vol57.ch03
Acker, B. A., Badescu, V. O., Berkenpas, M. B., Groppi, V. E., Hajós, M., Higdon, N. R., Hurst, R. S., Jacobsen, E. J., Margolis, B. J., McWhorter, W. W., et al. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129433
Synthèse d'antidotes multi-cibles contre les intoxications par des neurotoxiques organophosphorés.
Dubois-Geoffroy, P. (2021) · theses.fr (ABES) · doi:10.70675/f1f8e2eaz34bcz4456zb3ffz3dd9ddd60e42
THE TOXICITY OF AMMONIA: A THEORETICAL APPROACH
Vieira, A. B. C. D. (2024) · Seven Editora eBooks · doi:10.56238/sevened2024.033-005
(Eco)toxicokinetic Evaluation of the Natural Larvicide Cardanol Diene Against Aedes aegypti
de Sousa, D. S., Belarmino, A. B., da Rocha, M. N., Marinho, M. M., Mendes, F. R. D. S., & Marinho, G. S. (2024) · Ensaios e Ciência C Biológicas Agrárias e da Saúde · doi:10.17921/1415-6938.2024v28n3p334-341
Брель, А. К., Лисина, С. В., DYACHKOV, S. I., & Budaeva, J. N. (2024) · IZVESTIA VOLGOGRAD STATE TECHNICAL UNIVERSITY · doi:10.35211/1990-5297-2024-12-295-14-20
Jurutka, P. W., Khan, Z., Kaneko, I., Sausedo, M. A., Shahani, P. H., MacNeill, M., Grozić, A., Bhogal, J. S., Swierski, J. C., Wentzel, M. R., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.118059
Girst, G. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12280
Hybrids of 4-aminoquinolines and adamantane as inhibitors of AChE
Komatović, K., Matošević, A., Zlatović, M. V., Sladić, D. M., Bosak, A., & Opsenica, D. (2025) · Journal of the Serbian Chemical Society · doi:10.2298/jsc250131014k
Lima, J. N. M., Barbosa, C. R. D. S., dos Santos, J. F. S., Scherf, J. R., de Freitas, T. S., da Silva, L., Macêdo, N. S., Tahim, C. M., Lucetti, E. C. P., Marinho, E. S., et al. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100194
Schultz, D. (2025) · Wiley eBooks · doi:10.1002/0471266949.bmc305
Pinheiro, N. A. P., Romão, I. C., Alves, A. M. B., Siqueira, S. M. C., de Menezes, J. E. S. A., Marinho, E. S., Marinho, M. M., Magalhães, H. D. S., Gomes, A. F. D. C., Pessoa, O. D. L., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500016
“According to Wager et al. [24], weak bases with low lipophilicity (logP ≤ 3) that are larger and more polar (topological polar surface area [TPSA] 40–90 Å 2 ) than commonly active compounds in the CNS demonstrate a positive correlation between safety and in vitro absorption, distribution,…”
Radiofluorinated Analogs of NCS-382 as Potential PET Tracers for Imaging the CaMKIIα Hub Domain
Sirocchi, L. S., Stotz, S., Müller, M., Pedersen, N. B., Thiesen, L., Mattiussi, S., Avgerinos, C., Shalgunov, V., Wellendorph, P., Frølund, B., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00778
Antinociceptive and Anti‐inflammatory Effect of Nicandrin B Isolated From Datura ferox in Zebrafish
Maciel, J. B., Liberato, H. R., da Silva, A. W., Pereira, M., Rebouças, E. D. L., Pinto, F. D. C. L., da Rocha, M. N., Ferreira, M. K. A., Evangelista, J. S. A. M., Guedes, I. F., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202501221
Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastoma
Coker, J. A., Martinez, S. R., Han, S. H., Sloan, A. R., Gupta, A. K., Bukenya, G., Polzer, P. M., Ramos, J. H., Rico, E. G., Rico, A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.198298
TEIXEIRA, C. R., Romão, I. C., Ceballos, N. M., Lúcio, F. N. M., Frederico, M. J. S., de Albuquerque, R. L., Marinho, M. M., Teixeira, A. M. R., Marinho, E. S., Gomes, A. F. D. C., et al. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.143969
de Oliveira, B. R., de Albuquerque, R. L., Ferreira, M. K. A., Maciel, J. B., Guedes, J. M., Marinho, E. S., de Menezes, J. E. S. A., de Oliveira, M. D. C. F., de Mattos, M. C., & dos Santos, H. S. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144056
Silveira, Z. D. S., Macêdo, N. S., Barbosa, C. R. D. S., de Araújo, A. C. J., Miranda, G. M., Borges, J. A. D. O., Oliveira–Tintino, C. D. D. M., Tintino, S. R., Alves, J. V. D. O., Correia, M. T. D. S., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108057
Tissue targeting approaches for drug delivery
Zhang, D., Su, D., Alicea-Salas, J. Y., Zang, R., & Wright, M. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00049-2
Inhibition of N-type calcium channels by phenoxyanilide analogues
Bispat, A. S., Cardoso, F. C., Hasan, M. M., Adams, C. E., Lewis, R. J., Duggan, P. J., & Tuck, K. L. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118449
Yang, Z., & Xiao, Y. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2507.18557
“These approaches provided simple and interpretable filters widely used in early-stage drug screening to rapidly eliminate undesirable compounds, especially in settings where only limited experimental data were available[17,22–24].”
Yang, X., Lee, J., Moghadam, F. A., Steiner, J. P., Kim, S., Ganjur, N., de Almenara, A. J., Stoltz, B. M., Loh, Y. P., & Goddard, W. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2505359122
“…profile for neurodegenerative diseases localized in the brain, we integrated machine learning algorithms to evaluate physicochemical properties, make blood–brain barrier (BBB) penetration predictions, ( 23 ) and perform central nervous system multiparameter optimization (CNS MPO) scores ( 24 ).”
Cioffi, C. L., Pati, T. K., Lotsaris, I., Jayakumar, S., Peiser-Oliver, J., Mahesh, G., Chater, R. C., Jayaraman, A., Frangos, Z. J., Suleria, K., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03329
Mudududdla, R., Wong, S. W., Nguyen, N. H., Xue, L., Stashko, M. A., Wang, X., Vivash, L. E., Binder, M. D., Ackermann, U., Bozikis, Y. E., et al. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md00695c
Cavalcante, M. M. B., TEIXEIRA, C. R., Ferreira, M. K. A., Mendes, F. R. D. S., Maciel, J. B., de Menezes, J. E. S. A., Roberto, C. H. A., da Rocha, M. N., Marinho, M. M., Marinho, E. S., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153106
Investigating substituted phenylacetamide ligands in the D4R extended binding pocket
Li, T., Alkhatib, M., Ramdhan, P., Bourn, L. A., Rainwater, J., NGUYEN, N. V., Farrington, C. P., Lewis, B., Li, C., Keck, T. M., et al. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130660
Quinlan, R. B. A. (2021) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-54g4n8mwe
Additional file 1 of Human-in-the-loop assisted de novo molecular design
Sundin, I., Voronov, A., Xiao, H., Papadopoulos, K., Bjerrum, E. J., Heinonen, M., Patronov, A., Samuel Kaski, A., & Engkvist, O. (2024) · Figshare · doi:10.6084/m9.figshare.26557898
Binge-Like Alcohol Drinking: The Intersection of Ghrelin, Stress, and Alcohol Use Disorder
Richardson, R. S. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/2swp-wg13
Clayton, B., Richardson, T. I., Putt, K. S., Beck, D., Massey, S. M., Utsuki, T., Visvanathan, R., Chu, S., Mason, E. R., Jordi, O. E., et al. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8364768
Metadata
- Authors
- Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Wager, Travis T.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-03-18
- Volume
- 7
- Issue
- 6
- Pages
- 767-775
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2300160852
- Cited by
- 653
- References
- 13
- Citations by year
- 2026: 104 · 2025: 121 · 2024: 103 · 2023: 75 · 2022: 72 · 2021: 45 · 2020: 37 · 2019: 32 · 2018: 40 · 2017: 19 · 2016: 5
- FWCI
- 30.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- ACS Chemical Neuroscience (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- desirability function, drug candidate design, ADME properties, blood-brain barrier permeability, ClogP, topological polar surface area, drug safety, drug discovery
- MeSH terms
- Algorithms, Animals, Biological Transport, Blood-Brain Barrier, Central Nervous System, Humans, Permeability, Drug Design, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.